Adverse Events Associated With Antibody-Drug Conjugates Across Cancer Types
Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.
Diagnosis & Disease Information
Identifying Prognostic Factors in Pleural Mesothelioma
Researchers have validated previously identified prognostic factors for pleural mesothelioma and identified “room for improvement” when predicting overall survival in this patient population.
Can a Breath Test Detect Mesothelioma? It’s Too Soon to Tell.
Researchers are evaluating whether a breath test can detect malignant pleural mesothelioma in patients with asbestos exposure, and early results suggest it may be possible.
MARS 2: Chemo Alone May Be Superior to Surgery Plus Chemo in Mesothelioma
Chemotherapy alone may produce better outcomes than surgery plus chemotherapy in patients with mesothelioma, the MARS 2 trial suggests.
Adding Ipilimumab to Nivolumab Doesn’t Provide Meaningful Benefit, Researchers Say
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.
Pegargiminase Prolongs PFS, OS in Nonepithelioid Pleural Mesothelioma
Adding pegargiminase to standard frontline chemotherapy improves outcomes in patients with nonepithelioid pleural mesothelioma, a phase 2/3 study suggests.
VT3989 Demonstrates Clinical Activity, Suggesting Hippo Pathway Is Druggable Target
The investigational drug VT3989 appears safe and can produce responses in patients with refractory mesothelioma or sarcoma, a phase 1 study suggests.
Johnson & Johnson Offers $8.9 Billion to Settle Talcum Powder Lawsuits
Johnson & Johnson has offered to pay $8.9 billion to settle lawsuits alleging that the company’s talcum-based baby powder caused ovarian cancer and mesothelioma.
Pembrolizumab Demonstrates Activity in Diffuse Malignant Peritoneal Mesothelioma
Pembrolizumab can produce responses in patients with diffuse malignant peritoneal mesothelioma, according to a retrospective study.
Global Incidence of Mesothelioma on the Decline
The global incidence of mesothelioma has decreased in recent years, especially in highly developed countries, researchers found.
- Loading...
Loading...
Next post in Lung Cancer
Loading... 
Loading...